Castle Biosciences Inc. (CSTL)

Castle Biosciences Inc. (CSTL) – FDA

Mar 7, 2024 07:03 AM Castle Biosciences (CSTL) Reports New Data Confirming DecisionDx-SCC Provides Significant and Clinically Actionable Risk-Stratification of Patients
Feb 26, 2024 07:01 AM Castle Biosciences Inc. (CSTL) Announces Study Finds DecisionDx-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma
Jan 18, 2024 07:02 AM
Oct 3, 2023 07:03 AM
Jul 7, 2023 07:51 AM
Jun 12, 2023 07:03 AM
May 31, 2023 07:02 AM
May 3, 2023 07:06 AM
Nov 15, 2022 07:03 AM
Oct 24, 2022 07:04 AM
Oct 20, 2022 05:00 PM
Oct 13, 2022 07:05 AM
Sep 23, 2022 07:03 AM
Apr 27, 2022 07:05 AM
Mar 11, 2022 07:02 AM
Jan 12, 2022 07:00 AM
Nov 8, 2021 05:09 AM
Oct 26, 2021 07:09 AM
Sep 16, 2021 07:03 AM
Aug 16, 2021 07:09 AM
Jul 23, 2021 07:05 AM
Jun 9, 2021 07:02 AM
May 5, 2021 07:24 AM
Apr 14, 2021 07:06 AM
Dec 4, 2020 07:01 AM
Nov 17, 2020 07:12 AM
Nov 12, 2020 07:05 AM
Jul 9, 2020 08:19 AM
May 19, 2020 07:02 AM
Dec 30, 2019 07:01 AM